Cargando…

Tacrolimus in preventing transplant rejection in Chinese patients – optimizing use

Tacrolimus is a product of fermentation of Streptomyces, and belongs to the family of calcineurin inhibitors. It is a widely used immunosuppressive drug for preventing solid-organ transplant rejection. Compared to cyclosporine, tacrolimus has greater immunosuppressive potency and a lower incidence o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Chuan-Jiang, Li, Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298305/ https://www.ncbi.nlm.nih.gov/pubmed/25609922 http://dx.doi.org/10.2147/DDDT.S41349

Ejemplares similares

Role of tacrolimus combination therapy with mycophenolate mofetil in the prevention of organ rejection in kidney transplant patients
por: Dalal, P, et al.
Publicado: (2010)

Preventing Rejection of the Kidney Transplant
por: Malhotra, Divyanshu, et al.
Publicado: (2023)

Implantable Immunosuppressant Delivery to Prevent Rejection in Transplantation
por: Anggelia, Madonna Rica, et al.
Publicado: (2022)

Immunological Monitoring of Renal Transplant Recipients to Predict Acute Allograft Rejection Following the Discontinuation of Tacrolimus
por: Kreijveld, Ellen, et al.
Publicado: (2008)

Tacrolimus Concentration Is Effectively Predicted Using Combined Clinical and Genetic Factors in the Perioperative Period of Kidney Transplantation and Associated with Acute Rejection
por: Cheng, Fang, et al.
Publicado: (2022)

The Population Pharmacokinetic Models of Tacrolimus in Chinese Adult Liver Transplantation Patients
por: Zhu, Liqin, et al.
Publicado: (2014)

The pharmacokinetic study of tacrolimus and Wuzhi capsule in Chinese liver transplant patients
por: Qu, Jinlong, et al.
Publicado: (2022)

Tacrolimus intra-patient variability is not associated with chronic active antibody mediated rejection
por: Sablik, Kasia A., et al.
Publicado: (2018)

Influence of IL-18 and IL-10 Polymorphisms on Tacrolimus Elimination in Chinese Lung Transplant Patients
por: Zhang, Xiaoqing, et al.
Publicado: (2017)

Development and effects of tacrolimus-loaded nanoparticles on the inhibition of corneal allograft rejection
por: Wu, Qianni, et al.
Publicado: (2019)

Early Immunosuppressive Exposure of Enteric-Coated-Mycophenolate Sodium Plus Tacrolimus Associated with Acute Rejection in Expanded Criteria Donor Kidney Transplantation
por: Ding, Chen-Guang, et al.
Publicado: (2018)

Superior rejection profile during the first 24 months after heart transplantation under tacrolimus as baseline immunosuppressive regimen
por: Helmschrott, Matthias, et al.
Publicado: (2014)

Immunosuppression with generic tacrolimus in liver and kidney transplantation—systematic review and meta‐analysis on biopsy‐proven acute rejection and bioequivalence
por: Kahn, Judith, et al.
Publicado: (2020)

Pathophysiology of Rejection in Kidney Transplantation
por: Tamargo, Christina L., et al.
Publicado: (2023)

Prevention of acute rejection after rescue with Belatacept by association of low-dose Tacrolimus maintenance in medically complex kidney transplant recipients with early or late graft dysfunction
por: Gallo, Ester, et al.
Publicado: (2020)

High tacrolimus intra-patient variability is associated with graft rejection, and de novo donor-specific antibodies occurrence after liver transplantation
por: Del Bello, Arnaud, et al.
Publicado: (2018)

Nanomedicines in renal transplant rejection – focus on sirolimus
por: Shen, Li-Jiuan, et al.
Publicado: (2007)

A Low Fixed Tacrolimus Starting Dose Is Effective and Safe in Chinese Renal Transplantation Recipients
por: Tang, Jiang-Tao, et al.
Publicado: (2018)

Local Immunomodulatory Strategies to Prevent Allo‐Rejection in Transplantation of Insulin‐Producing Cells
por: Wang, Xi, et al.
Publicado: (2021)

Mechanism of cellular rejection in transplantation
por: Ingulli, Elizabeth
Publicado: (2010)

Population Pharmacokinetics and Initial Dosage Optimization of Tacrolimus in Pediatric Hematopoietic Stem Cell Transplant Patients
por: Liu, Xiao-Lin, et al.
Publicado: (2022)

Higher tacrolimus trough levels and time in the therapeutic range are associated with the risk of acute rejection in the first month after renal transplantation
por: Nguyen, Thi Van Anh, et al.
Publicado: (2023)

Immunomics of Renal Allograft Acute T Cell-Mediated Rejection Biopsies of Tacrolimus- and Belatacept-Treated Patients
por: van der Zwan, Marieke, et al.
Publicado: (2018)

Advanced Morphologic Analysis for Diagnosing Allograft Rejection: The Case of Cardiac Transplant Rejection
por: Peyster, Eliot G., et al.
Publicado: (2018)

Genomewide association study identifies a novel variant associated with tacrolimus trough concentration in Chinese renal transplant recipients
por: Yang, Siyao, et al.
Publicado: (2022)

Small Extracellular Vesicles in Transplant Rejection
por: Gołębiewska, Justyna E., et al.
Publicado: (2021)

Current Therapies in Kidney Transplant Rejection
por: Alasfar, Sami, et al.
Publicado: (2023)

Impact of the CYP3A5, CYP3A4, COMT, IL-10 and POR Genetic Polymorphisms on Tacrolimus Metabolism in Chinese Renal Transplant Recipients
por: Li, Chuan-Jiang, et al.
Publicado: (2014)

Profile of belatacept and its potential role in prevention of graft rejection following renal transplantation
por: Gupta, Gaurav, et al.
Publicado: (2010)

Belatacept for prevention of acute rejection in adult patients who have had a kidney transplant: an update
por: Wojciechowski, David, et al.
Publicado: (2012)

Optimizing rejection readouts in a corneal allograft transplantation model
por: Lapp, Thabo, et al.
Publicado: (2016)

Association between time in therapeutic range of tacrolimus blood concentration and acute rejection within the first three months after lung transplantation
por: Katada, Yoshiki, et al.
Publicado: (2022)

Statin therapy for preventing cardiovascular diseases in patients treated with tacrolimus after kidney transplantation
por: Han, Nayoung, et al.
Publicado: (2017)

Pharmacokinetic Evaluation of Tacrolimus in Chinese Adult Patients during the Early Stages Post-Lung Transplantation
por: Cui, Yi-Fan, et al.
Publicado: (2023)

Update on the clinical utility of once-daily tacrolimus in the management of transplantation
por: Posadas Salas, Maria Aurora, et al.
Publicado: (2014)

Kidney Transplant Rejection: Diagnosis and Treatment
por: Nasri-Chenijani, Sina
Publicado: (1987)

Corneal Transplant Rejections in Patients Receiving Immune Checkpoint Inhibitors
por: Moshirfar, Majid, et al.
Publicado: (2022)

Anti-interleukin-2 receptor antibodies—basiliximab and daclizumab—for the prevention of acute rejection in renal transplantation
por: Sageshima, Junichiro, et al.
Publicado: (2009)

Clinical impact using low-dose mycophenolate mofetil with tacrolimus on infectious, noninfectious complications and acute rejection, in renal transplant: A single hospital experience in Mexico
por: Andrade-Sierra, Jorge, et al.
Publicado: (2023)

Initial mycophenolate dose in tacrolimus treated renal transplant recipients, a cohort study comparing leukopaenia, rejection and long-term graft function
por: Dave, Vatsa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g7mamp949qo7aesf5c3rlduhdo